Table 1

Baseline clinical and viro-immunological characteristics of 97 HIV-infected pregnant women naive for any antiretroviral drug
Characteristics All pregnant women
n° 97
Age, years, mean ± SD; median, (IQR) 29,±5; 28 (25–32)
Gestational age at enrolment, week, mean ± SD 20 ± 5
Height at screening, cm, median (IQR) 155 (153–159)
Race/ethnicity, n. (%)
     Black African 97 (100)
Education, n. (%)
    Primary school 66 (68.0)
    Secondary school 17 (17.5)
    Other or unknown 14 (14.5)
Number of pregnancies, mean ± SD 3 ±1
Number of deliveries, mean ± SD 2 ±1
Number of children, mean +/-SD 1 ±1
HIV risk factor, n. (%)
     Unprotected heterosexual relationship 97 (100)
WHO stage, n. (%)
    1 53 (54.6)
    2 27 (27.8)
    3 15 (15.5)
    4 2 (2.1)
Days since HIV diagnosis, median (IQR) 136 (94–164)
MedianCD4+ cells at enrolment /μL (IQR) 392 (260–528)
Median log10 HIV RNA copies/mL (IQR) 4.80 (4.03–9.28)
Eligible for HAART, n (%) 19 (19.6%)
Positive VDRL assay, n (%) 3 (3.1)

Note. IQR Interquartile Range, SD Standard Deviation.

Vairo et al.

Vairo et al. BMC Infectious Diseases 2013 13:439   doi:10.1186/1471-2334-13-439

Open Data